CLIA Waiver, Oral Fluid Claim Next For HHS-Backed OraQuick Rapid HIV Test
This article was originally published in The Gray Sheet
Executive Summary
OraSure and FDA are discussing a CLIA waiver protocol the company has submitted for its OraQuick rapid HIV diagnostic test, which gained premarket approval Nov. 7